Are you sure you want to exit?
Any unsave changes will be lost.
Alexion
Infection prevention and Control
United States of America (USA), North America
Alexion Announces Plans to Initiate Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
https://alexion.com/our-commitment/covid-19